Advertisement

Generex Biotechnology Corp. has acquired a 51 percent stake in Global Medical Direct LLC, a provider of direct-to-consumer diabetes supplies and medications.

The Worcester-based biotech is focused on drug delivery for metabolic diseases, including diabetes, through the inner lining of the mouth.

SOURCE

Advertisement
Advertisement